Trulieve Cannabis Corp. TRLV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.08B | 1.14B | 1.17B | 1.18B | 1.19B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.08B | 1.14B | 1.17B | 1.18B | 1.19B |
| Cost of Revenue | 425.53M | 461.67M | 472.16M | 470.03M | 466.16M |
| Gross Profit | 655.49M | 677.33M | 697.96M | 711.10M | 723.02M |
| SG&A Expenses | 420.81M | 431.98M | 431.33M | 445.21M | 476.84M |
| Depreciation & Amortization | 102.57M | 114.32M | 118.03M | 117.61M | 116.85M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 948.91M | 1.01B | 1.02B | 1.03B | 1.06B |
| Operating Income | 132.11M | 131.02M | 148.61M | 148.28M | 129.32M |
| Income Before Tax | -328.25M | -325.98M | 96.33M | 91.43M | 75.63M |
| Income Tax Expenses | 117.98M | 144.76M | 177.52M | 208.12M | 207.79M |
| Earnings from Continuing Operations | -446.23 | -470.74 | -81.19 | -116.69 | -132.16 |
| Earnings from Discontinued Operations | -377.00K | -5.43M | -5.02M | -5.57M | -8.06M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.01M | 2.86M | 5.10M | 5.87M | 6.95M |
| Net Income | -445.60M | -473.30M | -81.11M | -116.39M | -133.27M |
| EBIT | 132.11M | 131.02M | 148.61M | 148.28M | 129.32M |
| EBITDA | 288.56M | 300.91M | 322.49M | 321.62M | 301.17M |
| EPS Basic | -2.31 | -2.46 | -0.42 | -0.61 | -0.65 |
| Normalized Basic EPS | -1.03 | -1.02 | 0.36 | 0.35 | 0.28 |
| EPS Diluted | -2.31 | -2.46 | -0.42 | -0.61 | -0.65 |
| Normalized Diluted EPS | -1.04 | -1.02 | 0.36 | 0.35 | 0.28 |
| Average Basic Shares Outstanding | 769.90M | 768.24M | 766.72M | 765.31M | 763.61M |
| Average Diluted Shares Outstanding | 777.57M | 768.24M | 766.72M | 765.31M | 763.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |